Onset of Glycemic and Weight Outcomes in Patients Initiating Exenatide Once Weekly: The Relationship of Exenatide Exposure with Efficacy over the First 24 Weeks of Treatment

Lignende værker

• Variability in and predictors of glycaemic responses after 24 weeks of treatment with exenatide twice daily and exenatide once weekly
  af: Shaw, Jonathan E., et al.
  Udgivet: (2017)
• DURATION-1: Exenatide Once Weekly Produces Sustained Glycemic Control and Weight Loss Over 52 Weeks
  af: Buse, John B., et al.
  Udgivet: (2010)
• Exenatide once weekly treatment maintained improvements in glycemic control and weight loss over 2 years
  af: Taylor, Kristin, et al.
  Udgivet: (2011)
• Effects of exenatide once weekly plus dapagliflozin, exenatide once weekly, or dapagliflozin, added to metformin monotherapy, on body weight, systolic blood pressure, and triglycerides in patients with type 2 diabetes in the DURATION‐8 study
  af: Jabbour, Serge A., et al.
  Udgivet: (2018)
• Effects of exenatide once weekly plus dapagliflozin, exenatide once weekly alone, or dapagliflozin alone added to metformin monotherapy in subgroups of patients with type 2 diabetes in the DURATION‐8 randomized controlled trial
  af: Frías, Juan P., et al.
  Udgivet: (2018)